Massimo Colombo
Impact in
- Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 66
- Hepatitis C virus research 46
- Hepatocellular Carcinoma Treatment and Prognosis 18
- Liver Disease and Transplantation 14
- Liver Diseases and Immunity 4
- Epidemiology 56
- Liver Disease Diagnosis and Treatment 54
- Hepatitis B Virus Studies 30
- Co-authors
- Morris ShermanMichel BeaugrandAndrew K. BurroughsErik ChristensenLuigi PagliaroRiccardo LencioniJordi BruixJuan Rodés
- Journals
- Journal of Hepatology (13 papers)Hepatology (10 papers)Gastroenterology (6 papers)Liver International (4 papers)PLoS ONE (2 papers)
- Partner nations
- ItalyUnited StatesCanada
In The Last Decade
Massimo Colombo
69 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Hepatology 6.1k
- Epidemiology 4.9k
- Cancer Research 441
- Surgery 1.1k
- Oncology 615
Countries citing papers authored by Massimo Colombo
This map shows the geographic impact of Massimo Colombo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Colombo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Colombo more than expected).
Fields of papers citing papers by Massimo Colombo
This network shows the impact of papers produced by Massimo Colombo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Colombo. The network helps show where Massimo Colombo may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Colombo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2021 | 10 | |
| 3 | 2018 | 23 | |
| 4 | Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment Hit paper breakdown → | 2017 | 271 |
| 5 | Treatment of patients with chronic hepatitis C infection in Lombardia: a report by the Lombardia Hepatitis Network. | 2016 | 1 |
| 6 | 2016 | 85 | |
| 7 | 2015 | 6 | |
| 8 | 2015 | 15 | |
| 9 | 2015 | 7 | |
| 10 | SVR12 Rate of 98.6% in 992 HCV Genotype 1b-Infected Patients Treated with ABT-450/r/Ombitasvir and Dasabuvir With or Without Ribavirin | 2014 | 2 |
| 11 | 2012 | 1 | |
| 12 | 2011 | 67 | |
| 13 | 2011 | 103 | |
| 14 | 2006 | 438 | |
| 15 | 2003 | 11 | |
| 16 | 2002 | 24 | |
| 17 | Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference Hit paper breakdown → | 2001 | 3380 |
| 18 | 1997 | 2 | |
| 19 | 1996 | 4 | |
| 20 | 1992 | 157 |
About Massimo Colombo
Massimo Colombo is a scholar working on Hepatology, Epidemiology, Rheumatology, Cancer Research and Gastroenterology, having authored 71 papers that have together received 7.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (54 papers), Hepatitis C virus research (46 papers), Hepatitis B Virus Studies (30 papers), Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease and Transplantation (14 papers), Systemic Lupus Erythematosus Research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Liver Diseases and Immunity (4 papers). The work is most often cited by research in Hepatology (6.1k citations), Epidemiology (4.9k citations), Cancer Research (441 citations), Surgery (1.1k citations) and Oncology (615 citations). Massimo Colombo has collaborated with scholars based in Italy, United States and Canada. Frequent co-authors include Morris Sherman, Michel Beaugrand, Andrew K. Burroughs, Erik Christensen, Luigi Pagliaro, Riccardo Lencioni, Jordi Bruix, Juan Rodés, Josep M. Llovet and Guido Ronchi. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, Liver International and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.